R&D Rare disease and the women's health gap For women with rare diseases, they often face a double jeopardy, where many of the symptoms they experience can be confused with and misdiagnosed.
R&D 5 takeaways from JP Morgan 2025 I’m back from another week in San Francisco, where as usual I heard from experts and prognosticators about their expectations for the coming year in biotech.
R&D The future of precision psychiatry The mental health clinical trials market is expected to double to $4.27 billion in 2028, up from $2.15 billion in 2018, and
R&D Changing Faces: Pharma and biotech November-December 2024 Welcome to the last edition of Changing Faces for 2024.
R&D JP Morgan Week 2025 - Day 3 pharmaphorum's JPM Week live blog finishes strong with panels on AI, funding, and a conference wrap-up.
R&D Pharma trends and predictions for 2025: An incoming CEO’s pe... Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape.
News Zuckerberg, Chan's Biohub launches protein 'world model' Chan Zuckberg Initiative-backed Biohub has made what it says is an AI-powered "world model" of protein biology available freely to researchers.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
